Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma S Jones

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 14, 2011
Sex-specific influence of angiotensin type 2 receptor stimulation on renal function: a novel therapeutic target for hypertensionLucinda M Hilliard, Emma S Jones, U Muscha Steckelings, et al.
International Journal of Cardiology|October 29, 2013
Direct AT₂ receptor stimulation is athero-protective and stabilizes plaque in apolipoprotein E-deficient miceSonja Tesanovic Kljajic, Robert E Widdop, Antony Vinh, et al.
American Journal of Infection Control|November 22, 2021
COVID-19 vaccination coverage among hospital-based healthcare personnel reported through the Department of Health and Human Services Unified Hospital Data Surveillance System, United States, January 20, 2021-September 15, 2021Hannah E Reses, Emma S Jones, Donald B Richardson, et al.
Hypertension (Dallas, Tex. : 1979)|August 20, 2008
Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female ratsAmanda K Sampson, Karen M Moritz, Emma S Jones, et al.
Hypertension (Dallas, Tex. : 1979)|November 30, 2011
Sex differences in the pressor and tubuloglomerular feedback response to angiotensin IIRussell D Brown, Lucinda M Hilliard, Geoffrey A Head, et al.
Current Opinion in Pharmacology|December 21, 2010
Non-peptide AT2-receptor agonistsU Muscha Steckelings, Mats Larhed, Anders Hallberg, et al.
Journal of the American Veterinary Medical Association|February 17, 2022
Large animal veterinarians' knowledge, attitudes, and practices regarding livestock abortion-associated zoonoses in the United States indicate potential occupational health riskCara C Cherry, María E Negrón Sureda, John D Gibbins, et al.
Open Forum Infectious Diseases|September 4, 2023
The Effect of Age on Dengue Presentation and the Diagnostic Accuracy of the 2015 Pan American Health Organization Case Criteria in a Puerto Rican CohortCamila D Odio, Liliana Sánchez-González, Mark Delorey, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Serelaxin and the AT<sub>2</sub> Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan CilexetilYan Wang, Lei Han, Matthew Shen, et al.
Experimental & Translational Stroke Medicine|August 28, 2012
Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivoSeyoung Lee, Vanessa H Brait, Thiruma V Arumugam, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Hypertension (Dallas, Tex. : 1979)|December 14, 2011
Sex-specific influence of angiotensin type 2 receptor stimulation on renal function: a novel therapeutic target for hypertensionLucinda M Hilliard, Emma S Jones, U Muscha Steckelings, et al.
International Journal of Cardiology|October 29, 2013
Direct AT₂ receptor stimulation is athero-protective and stabilizes plaque in apolipoprotein E-deficient miceSonja Tesanovic Kljajic, Robert E Widdop, Antony Vinh, et al.
American Journal of Infection Control|November 22, 2021
COVID-19 vaccination coverage among hospital-based healthcare personnel reported through the Department of Health and Human Services Unified Hospital Data Surveillance System, United States, January 20, 2021-September 15, 2021Hannah E Reses, Emma S Jones, Donald B Richardson, et al.
Hypertension (Dallas, Tex. : 1979)|August 20, 2008
Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female ratsAmanda K Sampson, Karen M Moritz, Emma S Jones, et al.
Hypertension (Dallas, Tex. : 1979)|November 30, 2011
Sex differences in the pressor and tubuloglomerular feedback response to angiotensin IIRussell D Brown, Lucinda M Hilliard, Geoffrey A Head, et al.
Current Opinion in Pharmacology|December 21, 2010
Non-peptide AT2-receptor agonistsU Muscha Steckelings, Mats Larhed, Anders Hallberg, et al.
Journal of the American Veterinary Medical Association|February 17, 2022
Large animal veterinarians' knowledge, attitudes, and practices regarding livestock abortion-associated zoonoses in the United States indicate potential occupational health riskCara C Cherry, María E Negrón Sureda, John D Gibbins, et al.
Open Forum Infectious Diseases|September 4, 2023
The Effect of Age on Dengue Presentation and the Diagnostic Accuracy of the 2015 Pan American Health Organization Case Criteria in a Puerto Rican CohortCamila D Odio, Liliana Sánchez-González, Mark Delorey, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Serelaxin and the AT<sub>2</sub> Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan CilexetilYan Wang, Lei Han, Matthew Shen, et al.
Experimental & Translational Stroke Medicine|August 28, 2012
Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivoSeyoung Lee, Vanessa H Brait, Thiruma V Arumugam, et al.
Pageof 4